Cyclic peptides are reshaping drug development and research, offering unique advantages over their linear counterparts....

Peptide-based radiopharmaceutical therapy (RPT), using chelating peptides to deliver radioisotopes directly to tumor sites, is...

Anaspec will be closed from Wednesday, December 24, 2025, through Friday, January 2, 2026....

AnaSpec is proud to introduce two powerful new products designed to support cutting-edge research into...

An EIND can be a patient’s lifeline. This article will examine the Emergency IND (EIND)...